FIELD: organic chemistry.
SUBSTANCE: invention relates to (S)-4-((1-benzylpyrrolidin-3-yl)(methyl)amino)-2-fluoro-5-methyl-N-(thiazol-4-yl)benzenesulfonamide or a pharmaceutically acceptable salt or solvate thereof. Invention also relates to a pharmaceutical composition based on said compound and use thereof.
EFFECT: obtaining a heterocyclic compound which is useful in treating a disease or condition associated with NaV1,6 activity, where the disease or condition is epilepsy and/or epileptic seizures.
12 cl, 1 tbl, 331 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INDAZOLE COMPOUNDS FOR USE IN TENDON AND/OR LIGAMENT INJURIES | 2017 |
|
RU2749547C2 |
| SODIUM CHANNEL BLOCKER | 2016 |
|
RU2705578C1 |
| (3-CYCLOALKYL-2, 3, 4, 5 - TETRAHYDRO-1H-BENZO [d] AZEPIN-7-YLOXY) DERIVATIVES, USE THEREOF FOR INHIBITING H3 RECEPTORS, PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD | 2003 |
|
RU2388752C2 |
| CYCLOALKANE DERIVATIVE | 2013 |
|
RU2635354C2 |
| SUBSTITUTED BENZENE COMPOUNDS | 2012 |
|
RU2629118C2 |
| PYRIDOXAZINONE DERIVATIVES AS TNAP INHIBITORS | 2016 |
|
RU2715704C2 |
| 5-FLUOROPYRIMIDINE DERIVATIVES AS FUNGICIDES | 2009 |
|
RU2522430C2 |
| THIAZOLYLPHENYL-BENZENESULFONAMIDO DERIVATIVES AS KINASE INHIBITORS | 2012 |
|
RU2606497C2 |
| CATHEPSIN-CYSTEINE PROTEASE INHIBITORS | 2003 |
|
RU2312861C2 |
| SELECTIVE GLYCOSIDASE INHIBITORS AND USE THEREOF | 2011 |
|
RU2592285C2 |
